Rare diseases
Investigational molecules
Locations
Recruiting trials first
11 clinical trials in this condition
Austria
Belgium
GermanyAustriaIn short
Adrenogenital syndrome, also known as congenital adrenal hyperplasia, is a genetic condition that disrupts the normal production of vital hormones in the adrenal glands. Early and accurate diagnosis is essential to manage the condition effectively and prevent serious complications. Understanding when to seek testing and what diagnostic methods are available can help individuals and families navigate this complex condition with greater confidence.
Diagnostic testing for adrenogenital syndrome is important for several groups of people at different stages of life. The timing and approach to testing often depend on family history, symptoms, and the severity of the condition.
All newborns in the United States and many other countries are routinely screened for this condition within the first few days of life. This screening is done through a simple heel stick blood test as part of standard newborn screening programs. Early detection through newborn screening is crucial because it can identify the classic form of the condition before serious symptoms develop, allowing treatment to begin immediately.
Parents who have a family history of adrenogenital syndrome may want to consider prenatal testing, which means testing before the baby is born. This is especially relevant if either parent carries the genetic mutation that causes the condition. Prenatal testing can help families prepare for the care their baby may need right from birth.
For female infants, if doctors notice that the outer genitals look different than what is typically expected, this is often the first sign that prompts immediate diagnostic investigation. This physical finding, called ambiguous genitalia, means the external sex organs are not clearly male or female. Males with the condition typically have normal-appearing genitals at birth, which means they may not be diagnosed until symptoms appear.
Infants who show concerning symptoms within the first few weeks of life should be tested urgently. Warning signs include poor feeding, vomiting, diarrhea, loss of weight, and signs of dehydration. These symptoms can develop when the body cannot properly regulate salt and water balance, which happens in the most severe form of the condition called salt-wasting type. Without prompt diagnosis and treatment, these symptoms can become life-threatening.
Children and adolescents who were not diagnosed as newborns may need testing if they develop certain symptoms later in life. For girls and young women, these symptoms might include very early appearance of pubic or armpit hair, severe acne, excessive facial or body hair, irregular or absent menstrual periods, and some enlargement of the clitoris. For boys, signs might include early puberty with a deepening voice, severe acne, early appearance of pubic or armpit hair, an enlarged penis but normal-sized testes, and unusually well-developed muscles for their age.
Another characteristic feature in both boys and girls is rapid growth during childhood, but then ending up much shorter than expected as adults. This happens because excess male hormones can cause the growth plates in bones to close too early. If parents notice their child is growing unusually fast but the doctor predicts they will be short as an adult, testing for adrenogenital syndrome may be warranted.
Adults who experience persistent fatigue, low blood pressure, dizziness, or reproductive issues may also benefit from diagnostic testing, especially if they have a milder form of the condition that was never diagnosed in childhood. Women might have fertility problems or menstrual irregularities that prompt investigation.
Healthcare professionals use a combination of physical examinations, blood tests, imaging studies, and sometimes genetic tests to diagnose adrenogenital syndrome. The specific tests ordered depend on the person's age, symptoms, and whether the condition is suspected before birth, at birth, or later in life.
A thorough physical examination is often the first step in diagnosis. The doctor will check blood pressure and heart rate, as the condition can affect both. They will also look for physical signs that suggest hormone imbalances. In female infants, the doctor will carefully examine the genitals to see if they appear different than expected, which is often the first clue to the diagnosis. For older children and adults, the doctor will assess signs of early puberty, excess body hair, acne, and growth patterns.
The newborn screening test is performed using a few drops of blood taken from the baby's heel, usually within the first few days after birth. This test looks for elevated levels of a hormone called 17-hydroxyprogesterone, which builds up when the body cannot make enough cortisol. This screening can detect the classic form of adrenogenital syndrome but does not identify the milder nonclassic form. A positive screening test needs to be confirmed with additional testing.
Blood tests are the cornerstone of diagnosing adrenogenital syndrome at any age. These tests measure the levels of various hormones produced by the adrenal glands to determine which ones are too high or too low. The most common blood tests include measurements of cortisol, which regulates stress response and blood pressure; aldosterone, which controls salt and water balance; and androgens like testosterone, which are male sex hormones.
Doctors also measure 17-hydroxyprogesterone, a substance that accumulates when the enzyme needed to make cortisol is missing. Very high levels of this hormone strongly suggest adrenogenital syndrome. Another important test measures renin, a substance the body produces when salt levels are low, which helps identify the salt-wasting type of the condition.
Measuring electrolytes in the blood is crucial for diagnosing the salt-wasting form of adrenogenital syndrome. These tests check the levels of sodium and potassium. People with the salt-wasting form typically have low sodium and high potassium, along with other blood chemistry abnormalities like low blood sugar and too much acid in the blood. These imbalances can cause serious symptoms and require immediate treatment.
When female infants have ambiguous genitalia, doctors may order imaging tests to see the internal reproductive organs. An ultrasound of the pelvis uses sound waves to create pictures of the inside of the body. This painless test can show whether the baby has a uterus and ovaries, which confirms the infant is genetically female despite the appearance of the external genitals.
In cases where the sex of the infant is unclear based on physical examination, doctors may perform a karyotype test. This test looks at the chromosomes inside cells to determine genetic sex. Females typically have two X chromosomes, while males have one X and one Y chromosome. This test helps doctors understand the underlying biology even when the external appearance is confusing.
Genetic tests can identify the specific gene mutation causing adrenogenital syndrome. Most people with the condition have mutations in a gene that provides instructions for making an enzyme called 21-hydroxylase. While genetic testing can confirm the diagnosis, it is not always necessary because blood tests showing hormone imbalances are usually sufficient. However, genetic testing may be helpful for family planning or when the diagnosis is uncertain.
For families with a history of adrenogenital syndrome, testing can be done during pregnancy to determine if the baby has the condition. Two main procedures are used: amniocentesis and chorionic villus sampling. Amniocentesis involves using a needle to remove a small amount of the fluid that surrounds the baby in the womb. The cells in this fluid are then analyzed. Chorionic villus sampling removes a small sample of tissue from the placenta, the organ that provides nutrients to the developing baby. Both procedures allow genetic testing of the baby before birth, though they do carry small risks.
Doctors must carefully consider other conditions that can cause similar symptoms. In newborns with ambiguous genitals, other genetic conditions affecting sexual development need to be ruled out. In children with early puberty, other causes of hormone excess must be considered. Blood tests showing the specific pattern of low cortisol, low or absent aldosterone, and high androgens help distinguish adrenogenital syndrome from other endocrine disorders. The combination of clinical findings, hormone test results, and sometimes genetic confirmation allows doctors to make an accurate diagnosis and distinguish this condition from others that may look similar.
When individuals with adrenogenital syndrome consider participating in clinical trials, they typically need to undergo a comprehensive set of diagnostic tests to determine if they meet the study's eligibility criteria. These requirements are in place to ensure patient safety and to establish a clear baseline for measuring how well the experimental treatment works.
Clinical trials for adrenogenital syndrome generally require confirmed diagnosis through blood tests showing characteristic hormone imbalances. Researchers need documented evidence that participants have the classic form of the condition, usually confirmed by measuring very high levels of 17-hydroxyprogesterone and low cortisol levels. Some trials may also require genetic testing to confirm mutations in specific genes, most commonly the gene for 21-hydroxylase enzyme.
Baseline hormone measurements are essential before starting any clinical trial. These include detailed assessments of cortisol, aldosterone, various androgens, and related hormones throughout the day. Some studies may require special testing called an ACTH stimulation test, where doctors give a synthetic hormone and then measure how the adrenal glands respond. This helps researchers understand how well the adrenal glands are functioning before the experimental treatment begins.
Blood pressure and heart rate monitoring are standard requirements because adrenogenital syndrome affects cardiovascular health. Researchers need to document baseline blood pressure patterns and ensure that participants are stable enough to safely receive the experimental treatment.
Electrolyte measurements, including sodium and potassium levels, must be stable before enrollment. Clinical trials generally exclude people whose salt balance is severely disrupted or who have had recent adrenal crises, as these individuals need to focus on stabilizing their condition before considering experimental treatments.
Imaging studies may be required depending on the trial's focus. Some studies might need pelvic ultrasounds to document the anatomy of reproductive organs, especially in trials studying fertility or surgical interventions. Other trials might require CT scans or MRI of the adrenal glands to assess their size and structure.
For newer treatment approaches being investigated, such as gene therapy trials, additional specialized tests may be required. These might include more extensive genetic analysis, immune system function tests, and detailed assessments of organ function to ensure the body can safely handle the experimental therapy. Gene therapy trials may have very specific requirements for which genetic mutations qualify for participation.
Participants are typically required to have tried standard treatments first and to maintain stable doses of their regular medications for a certain period before joining a trial. This helps researchers isolate the effects of the experimental treatment from changes in background therapy. Documentation of current medication regimens, including doses of hydrocortisone, fludrocortisone, and any salt supplements, is always required.
Age requirements vary by trial, but many studies separate participants into age groups because the condition affects children and adults differently. Pediatric trials often require growth measurements and bone age assessments, which involve taking an X-ray of the hand to see how mature the bones are compared to the child's chronological age. Adult trials may focus more on reproductive health, fertility assessments, and long-term cardiovascular risk markers.
Quality of life assessments and symptom questionnaires are commonly used in clinical trials to measure how the condition affects daily living. While not diagnostic tests in the traditional sense, these standardized questionnaires help researchers understand the full impact of the experimental treatment beyond just laboratory values.
Safety monitoring during the trial involves regular repeat testing of all baseline measurements. Blood tests for hormone levels, electrolytes, blood counts, and organ function are checked frequently to catch any problems early. This close monitoring ensures that participants receive the safest possible care while contributing to research that may help future patients with adrenogenital syndrome.
This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
